SCHEMBL18795995

SCHEMBL18795995

Cc1nc2c(F)c(F)ccc2nc1Oc1ccc(Cl)cc1Br

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.38
SLC6A2 P23975 3/20 0.38
SLC6A4 P31645 3/20 0.38
EPAS1 Q99814 3/20 0.37
SLC6A3 Q01959 1/20 0.36
S1PR4 O95977 1/20 0.35
AMY1A P0DUB6 4/20 0.34
NPC1 O15118 2/20 0.34
RAB9A P51151 1/20 0.34
ALDH1A1 P00352 2/20 0.34
HPGD P15428 2/20 0.34
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
MAPT P10636 2/20 0.33
LMNA P02545 1/20 0.33
HTT P42858 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
NR2F2 P24468 1/20 0.33
PDE2A O00408 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18796089 0.90 AMY1A (0.34) SLC6A4EPAS1AMY1ANPC1RAB9A
SCHEMBL18796202 0.89 LYN (0.37) L3MBTL1EPAS1AMY1AMAPTHTT
SCHEMBL18795994 0.89 MAPT (0.34) L3MBTL1NPC1RAB9AALDH1A1HPGD
SCHEMBL18796223 0.83 LCK (0.40) L3MBTL1NPC1RAB9AALDH1A1KDM4E
SCHEMBL20552245 0.83 LMNA (0.32) AMY1AHPGDKDM4ELMNASMN1; SMN2
SCHEMBL20551125 0.82 GCK (0.31) HPGDKDM4E
SCHEMBL18796200 0.81 KMT2A (0.33) KMT2A
SCHEMBL18796315 0.81 AMY1A (0.35) AMY1APDE2APDE10A
SCHEMBL20551188 0.81 KDM4E (0.30) HPGDKDM4E
SCHEMBL18796275 0.79 NQO2 (0.32) SLC6A2SLC6A4SLC6A3HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3368514-B1 TRISUBSTITUTED SILYLPHENOXYHETEROCYCLES AND ANALOGUES BAYER CROPSCIENCE AG (DE) 2021-08-18 EP disclosed
US-10683311-B2 Trisubstitutedsilylphenoxyheterocycles and analogues BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2020-06-16 US disclosed
US-20190233444-A1 TRISUBSTITUTEDSILYLPHENOXYHETEROCYCLES AND ANALOGUES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2019-08-01 US disclosed
EP-3368514-A1 TRISUBSTITUTEDSILYLPHENOXYHETEROCYCLES AND ANALOGUES Bayer CropScience Aktiengesellschaft (DE) 2018-09-05 EP disclosed
WO-2017072283-A1 TRISUBSTITUTEDSILYLPHENOXYHETEROCYCLES AND ANALOGUES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2017-05-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10683311-B2 Trisubstitutedsilylphenoxyheterocycles and analogues PIK3C3, ERG28, DDT L3MBTL1 2453/4885SLC6A2 4269/4885SLC6A4 3960/4885
US-20190233444-A1 TRISUBSTITUTEDSILYLPHENOXYHETEROCYCLES AND ANALOGUES PIK3C3, ERG28, DDT L3MBTL1 2453/4885SLC6A2 4269/4885SLC6A4 3960/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.